Résumé

There has been growing interest in the use of cannabis-based products for the treatment of a wide range of diseases, including epilepsy. A number of studies were published during the last 5 years
demonstrating efficacy of purified CBD for the control of a large spectrum of seizure-types, particularly those observed in severe childhood epilepsies, such as Lennox- Gastaut and Dravet syndromes. This book, co-authored by leaders in the field of epileptology, critically reviews recent data from clinical trials. Authors discuss issues related to pharmacology, drug interactions, efficacy, potential adverse events and
long-term effects on development and behaviour. Child and adult neurologists and all clinicians contributing to epilepsy care will find useful information on the best practices, when using purified CBD for the treatment of
drug-resistant epilepsies.

Caractéristiques

Editeur : John Libbey

Auteur(s) : Alexis Arzimanoglou, Ulrich Brandl, J. Helen Cross, Antonio Gil-Nagel, Lieven Lagae, Cecilie Johannessen Landmark, Nicola Specchio, Elizabeth Thiele

Publication : 1 octobre 2020

Edition : 1ère édition

Intérieur : Noir & blanc

Support(s) : Text (eye-readable) [ePub]

Contenu(s) : ePub

Protection(s) : Marquage social (ePub)

Taille(s) : 5,2 Mo (ePub)

Langue(s) : Anglais

Code(s) CLIL : 3173

EAN13 Text (eye-readable) [ePub] : 9782742016570

EAN13 (papier) : 9782742016334

Référencer ce produit sur votre site

Du même thème

--:-- / --:--